메뉴 건너뛰기




Volumn 20, Issue 3, 2014, Pages 387-395

Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors

Author keywords

Allogeneic hematopoietic stem cell transplantation; Fatigue; Functional status; Health related quality of life; Symptom experience

Indexed keywords

ADOLESCENT; ADVERSE OUTCOME; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; DEMOGRAPHY; DISTRESS SYNDROME; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEALTH CARE; HEALTH STATUS; HISPANIC; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTCOME ASSESSMENT; PATIENT CARE; QUALITY OF LIFE; TRANSPLANTATION; WELLBEING;

EID: 84896831019     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2013.12.001     Document Type: Article
Times cited : (33)

References (56)
  • 1
    • 0037639971 scopus 로고    scopus 로고
    • The current status of hematopoietic cell transplantation
    • Appelbaum F.R. The current status of hematopoietic cell transplantation. Annu Rev Med 2003, 54:491-512.
    • (2003) Annu Rev Med , vol.54 , pp. 491-512
    • Appelbaum, F.R.1
  • 3
    • 79960030746 scopus 로고    scopus 로고
    • 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders
    • Available at:
    • Pasquini M.C., Wang Z., Horowitz M.M., Gale 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. Clin Transpl 2010, 87-105. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21696033.
    • (2010) Clin Transpl , pp. 87-105
    • Pasquini, M.C.1    Wang, Z.2    Horowitz, M.M.3
  • 4
    • 84883105163 scopus 로고    scopus 로고
    • Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors
    • Hahn T., McCarthy P.L., Hassebroek A., et al. Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors. JClin Oncol 2013, 31:2437-2449.
    • (2013) JClin Oncol , vol.31 , pp. 2437-2449
    • Hahn, T.1    McCarthy, P.L.2    Hassebroek, A.3
  • 5
    • 84863242119 scopus 로고    scopus 로고
    • Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
    • Majhail N.S., Rizzo J.D., Lee S.J., et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant 2012, 47:337-341.
    • (2012) Bone Marrow Transplant , vol.47 , pp. 337-341
    • Majhail, N.S.1    Rizzo, J.D.2    Lee, S.J.3
  • 6
    • 0028893864 scopus 로고
    • Linking clinical variables with health-related quality of life: A conceptual model of patient outcomes
    • Wilson I.B., Cleary P.D. Linking clinical variables with health-related quality of life: A conceptual model of patient outcomes. JAMA 1995, 273:59-65.
    • (1995) JAMA , vol.273 , pp. 59-65
    • Wilson, I.B.1    Cleary, P.D.2
  • 7
    • 66149093916 scopus 로고    scopus 로고
    • Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature
    • Mosher C.E., Redd W.H., Rini C.M., et al. Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psychooncology 2009, 18:113-127.
    • (2009) Psychooncology , vol.18 , pp. 113-127
    • Mosher, C.E.1    Redd, W.H.2    Rini, C.M.3
  • 8
    • 67651034480 scopus 로고    scopus 로고
    • Quality of life after allogeneic hematopoietic cell transplantation
    • Pidala J., Anasetti C., Jim H. Quality of life after allogeneic hematopoietic cell transplantation. Blood 2009, 114:7-19.
    • (2009) Blood , vol.114 , pp. 7-19
    • Pidala, J.1    Anasetti, C.2    Jim, H.3
  • 9
    • 84855368505 scopus 로고    scopus 로고
    • Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation
    • Norkin M., Hsu J.W., Wingard J.R. Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation. Semin Hematol 2012, 49:104-109.
    • (2012) Semin Hematol , vol.49 , pp. 104-109
    • Norkin, M.1    Hsu, J.W.2    Wingard, J.R.3
  • 10
    • 0032616588 scopus 로고    scopus 로고
    • Evaluation of the psychometric properties of the Spanish version of the Rotterdam Symptom Checklist to assess quality of life of cancer patients
    • Agra Y., Badia X. Evaluation of the psychometric properties of the Spanish version of the Rotterdam Symptom Checklist to assess quality of life of cancer patients. Rev Esp Salud Publica 1999, 73:35-44.
    • (1999) Rev Esp Salud Publica , vol.73 , pp. 35-44
    • Agra, Y.1    Badia, X.2
  • 11
    • 0026490638 scopus 로고
    • Quality of life: perceptions of long-term survivors of bone marrow transplantation
    • Belec R.H. Quality of life: perceptions of long-term survivors of bone marrow transplantation. Oncol Nurs Forum 1992, 19:31-37.
    • (1992) Oncol Nurs Forum , vol.19 , pp. 31-37
    • Belec, R.H.1
  • 12
    • 0030038441 scopus 로고    scopus 로고
    • Quality of life in long-term survivors of marrow transplantation: Comparison with a matched group receiving maintenance chemotherapy
    • Molassiotis A., Van Den Akker O.B.A., Milligan D.W., et al. Quality of life in long-term survivors of marrow transplantation: Comparison with a matched group receiving maintenance chemotherapy. Bone Marrow Transplant 1996, 17:249-258.
    • (1996) Bone Marrow Transplant , vol.17 , pp. 249-258
    • Molassiotis, A.1    Van Den Akker, O.B.A.2    Milligan, D.W.3
  • 13
    • 1242307289 scopus 로고    scopus 로고
    • Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life
    • Redaelli A., Stephens J.M., Brandt S., et al. Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life. Cancer Treat Rev 2004, 30:103-117.
    • (2004) Cancer Treat Rev , vol.30 , pp. 103-117
    • Redaelli, A.1    Stephens, J.M.2    Brandt, S.3
  • 14
    • 79955025408 scopus 로고    scopus 로고
    • Health-related quality of life following allogeneic hematopoietic stem cell transplantation
    • Bevans M. Health-related quality of life following allogeneic hematopoietic stem cell transplantation. Hematology Am Soc Hematol Educ Program 2010, 2010:248-254.
    • (2010) Hematology Am Soc Hematol Educ Program , vol.2010 , pp. 248-254
    • Bevans, M.1
  • 15
    • 84862939660 scopus 로고    scopus 로고
    • Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation
    • Khera N., Storer B., Flowers M.E., et al. Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantation. JClin Oncol 2012, 30:71-77.
    • (2012) JClin Oncol , vol.30 , pp. 71-77
    • Khera, N.1    Storer, B.2    Flowers, M.E.3
  • 16
    • 78149407957 scopus 로고    scopus 로고
    • Factors associated with self-reported physical and mental health after hematopoietic cell transplantation
    • Wingard J.R., Huang I.C., Sobocinski K.A., et al. Factors associated with self-reported physical and mental health after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010, 16:1682-1692.
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 1682-1692
    • Wingard, J.R.1    Huang, I.C.2    Sobocinski, K.A.3
  • 17
    • 77950627877 scopus 로고    scopus 로고
    • Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)
    • Mitchell S.A., Leidy N.K., Mooney K.H., et al. Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD). Bone Marrow Transplant 2010, 45:762-769.
    • (2010) Bone Marrow Transplant , vol.45 , pp. 762-769
    • Mitchell, S.A.1    Leidy, N.K.2    Mooney, K.H.3
  • 18
    • 79956291307 scopus 로고    scopus 로고
    • Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol
    • Bevans M.F., Mitchell S.A., Barrett A.J., et al. Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol. Health Qual Life Outcomes 2011, 9:24.
    • (2011) Health Qual Life Outcomes , vol.9 , pp. 24
    • Bevans, M.F.1    Mitchell, S.A.2    Barrett, A.J.3
  • 19
    • 0024337547 scopus 로고
    • Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival
    • Barrett A.J., Horowitz M.M., Gale R.P., et al. Marrow transplantation for acute lymphoblastic leukemia: factors affecting relapse and survival. Blood 1989, 74:862-871.
    • (1989) Blood , vol.74 , pp. 862-871
    • Barrett, A.J.1    Horowitz, M.M.2    Gale, R.P.3
  • 20
    • 0141537040 scopus 로고    scopus 로고
    • Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas
    • Bishop M.R., Hou J.W.S., Wilson W.H., et al. Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas. Biol Blood Marrow Transplant 2003, 9:162-169.
    • (2003) Biol Blood Marrow Transplant , vol.9 , pp. 162-169
    • Bishop, M.R.1    Hou, J.W.S.2    Wilson, W.H.3
  • 21
    • 0033024367 scopus 로고    scopus 로고
    • Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect
    • Childs R.W., Clave E., Tisdale J., et al. Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect. JClin Oncol 1999, 17:2044-2049.
    • (1999) JClin Oncol , vol.17 , pp. 2044-2049
    • Childs, R.W.1    Clave, E.2    Tisdale, J.3
  • 22
    • 84879448457 scopus 로고    scopus 로고
    • Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation
    • Fowler D.H., Mossoba M.E., Steinberg S.M., et al. Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation. Blood 2013, 121:2864-2874.
    • (2013) Blood , vol.121 , pp. 2864-2874
    • Fowler, D.H.1    Mossoba, M.E.2    Steinberg, S.M.3
  • 24
    • 0032063611 scopus 로고    scopus 로고
    • Discriminant and criterion validation of the US-Spanish version of the SF-36 health survey in a Cuban-American population with benign prostatic hyperplasia
    • Arocho R., McMillan C.A. Discriminant and criterion validation of the US-Spanish version of the SF-36 health survey in a Cuban-American population with benign prostatic hyperplasia. Med Care 1998, 36:766-772.
    • (1998) Med Care , vol.36 , pp. 766-772
    • Arocho, R.1    McMillan, C.A.2
  • 25
    • 0031932969 scopus 로고    scopus 로고
    • Construct validation of the USA-Spanish version of the SF-36 health survey in a Cuban-American population with benign prostatic hyperplasia
    • Arocho R., McMillan C.A., Sutton-Wallace P. Construct validation of the USA-Spanish version of the SF-36 health survey in a Cuban-American population with benign prostatic hyperplasia. Qual Life Res 1998, 7:121-126.
    • (1998) Qual Life Res , vol.7 , pp. 121-126
    • Arocho, R.1    McMillan, C.A.2    Sutton-Wallace, P.3
  • 26
    • 0032912344 scopus 로고    scopus 로고
    • Measuring health status in psychiatric community surveys: Internal and external validity of the Spanish version of the SF-36
    • Ayuso-Mateos J.L., Lasa L., Vazquez-Barquero J.L., et al. Measuring health status in psychiatric community surveys: Internal and external validity of the Spanish version of the SF-36. Acta Psychiatr Scand 1999, 99:26-32.
    • (1999) Acta Psychiatr Scand , vol.99 , pp. 26-32
    • Ayuso-Mateos, J.L.1    Lasa, L.2    Vazquez-Barquero, J.L.3
  • 27
    • 3042610431 scopus 로고    scopus 로고
    • Reliability and validity of the SF-36 among older Mexican Americans
    • Peek M.K., Ray L., Patel K., et al. Reliability and validity of the SF-36 among older Mexican Americans. Gerontologist 2004, 44:418-425.
    • (2004) Gerontologist , vol.44 , pp. 418-425
    • Peek, M.K.1    Ray, L.2    Patel, K.3
  • 28
    • 0027407786 scopus 로고
    • The functional assessment of cancer therapy scale: Development and validation of the general measure
    • Cella D.F., Tulsky D.S., Gray G., Sarafran B., Linn E., Bonomi A.E., et al. The functional assessment of cancer therapy scale: Development and validation of the general measure. Journal of Clinical Oncology 1993, 11:570-579.
    • (1993) Journal of Clinical Oncology , vol.11 , pp. 570-579
    • Cella, D.F.1    Tulsky, D.S.2    Gray, G.3    Sarafran, B.4    Linn, E.5    Bonomi, A.E.6
  • 29
    • 18244405303 scopus 로고    scopus 로고
    • General population and cancer patient norms for the functional assessment of cancer therapy-general (FACT-G)
    • Brucker P.S., Yost K., Cashy J., et al. General population and cancer patient norms for the functional assessment of cancer therapy-general (FACT-G). Eval Health Prof 2005, 28:192-211.
    • (2005) Eval Health Prof , vol.28 , pp. 192-211
    • Brucker, P.S.1    Yost, K.2    Cashy, J.3
  • 30
    • 0032158816 scopus 로고    scopus 로고
    • Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument
    • Cella D., Hernandez L., Bonomi A.E., et al. Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument. Med Care 1998, 36:1407-1418.
    • (1998) Med Care , vol.36 , pp. 1407-1418
    • Cella, D.1    Hernandez, L.2    Bonomi, A.E.3
  • 31
    • 4243183584 scopus 로고    scopus 로고
    • Evaluation of the Functional Assessment of Cancer Therapy-General (FACT-G) Spanish version 4 in South America: classic psychometric and item response theory analyses
    • Dapueto J.J., Francolino C., Servente L., et al. Evaluation of the Functional Assessment of Cancer Therapy-General (FACT-G) Spanish version 4 in South America: classic psychometric and item response theory analyses. Health Qual Life Outcomes 2003, 1:32.
    • (2003) Health Qual Life Outcomes , vol.1 , pp. 32
    • Dapueto, J.J.1    Francolino, C.2    Servente, L.3
  • 33
    • 84864467000 scopus 로고    scopus 로고
    • Adisease risk index for patients undergoing allogeneic stem cell transplantation
    • Armand P., Gibson C.J., Cutler C., et al. Adisease risk index for patients undergoing allogeneic stem cell transplantation. Blood 2012, 120:905-913.
    • (2012) Blood , vol.120 , pp. 905-913
    • Armand, P.1    Gibson, C.J.2    Cutler, C.3
  • 34
    • 84879441095 scopus 로고    scopus 로고
    • How I assess comorbidities before hematopoietic cell transplantation
    • Sorror M.L. How I assess comorbidities before hematopoietic cell transplantation. Blood 2013, 121:2854-2863.
    • (2013) Blood , vol.121 , pp. 2854-2863
    • Sorror, M.L.1
  • 35
    • 84875554257 scopus 로고    scopus 로고
    • National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis
    • Baird K., Steinberg S.M., Grkovic L., et al. National Institutes of Health chronic graft-versus-host disease staging in severely affected patients: organ and global scoring correlate with established indicators of disease severity and prognosis. Biol Blood Marrow Transplant 2013, 19:632-639.
    • (2013) Biol Blood Marrow Transplant , vol.19 , pp. 632-639
    • Baird, K.1    Steinberg, S.M.2    Grkovic, L.3
  • 36
    • 84867167966 scopus 로고    scopus 로고
    • Oral chronic graft-vs.-host disease characterization using the NIH scale
    • Fassil H., Bassim C.W., Mays J., et al. Oral chronic graft-vs.-host disease characterization using the NIH scale. JDent Res 2012, 91:S45-S51.
    • (2012) JDent Res , vol.91
    • Fassil, H.1    Bassim, C.W.2    Mays, J.3
  • 37
    • 84875203995 scopus 로고    scopus 로고
    • Health related quality of life among patients with chronic graft-versus-host disease in China
    • Mo X.D., Xu L.P., Liu D.H., et al. Health related quality of life among patients with chronic graft-versus-host disease in China. Chin Med J (Engl) 2013, 126:3048-3052.
    • (2013) Chin Med J (Engl) , vol.126 , pp. 3048-3052
    • Mo, X.D.1    Xu, L.P.2    Liu, D.H.3
  • 39
    • 77956892162 scopus 로고    scopus 로고
    • SAS Institute Inc., Cary, NC
    • SAS SAS System for Windows 2013, SAS Institute Inc., Cary, NC.
    • (2013) SAS System for Windows
  • 40
    • 2442590643 scopus 로고    scopus 로고
    • Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma
    • Syrjala K.L., Langer S.L., Abrams J.R., et al. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004, 291:2335-2343.
    • (2004) JAMA , vol.291 , pp. 2335-2343
    • Syrjala, K.L.1    Langer, S.L.2    Abrams, J.R.3
  • 41
    • 80055099118 scopus 로고    scopus 로고
    • Complacency is not an option
    • Bevans M.F. Complacency is not an option. Blood 2011, 118:4506-4507.
    • (2011) Blood , vol.118 , pp. 4506-4507
    • Bevans, M.F.1
  • 42
    • 53949117737 scopus 로고    scopus 로고
    • The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT)
    • Bevans M.F., Mitchell S.A., Marden S. The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT). Support Care Cancer 2008, 16:1243-1254.
    • (2008) Support Care Cancer , vol.16 , pp. 1243-1254
    • Bevans, M.F.1    Mitchell, S.A.2    Marden, S.3
  • 43
    • 84880219381 scopus 로고    scopus 로고
    • Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT
    • Daikeler T., Mauramo M., Rovo A., et al. Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT. Bone Marrow Transplant 2013, 48:988-993.
    • (2013) Bone Marrow Transplant , vol.48 , pp. 988-993
    • Daikeler, T.1    Mauramo, M.2    Rovo, A.3
  • 44
    • 77957938008 scopus 로고    scopus 로고
    • Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation
    • Pallua S., Giesinger J., Oberguggenberger A., et al. Impact of GvHD on quality of life in long-term survivors of haematopoietic transplantation. Bone Marrow Transplant 2010, 45:1534-1539.
    • (2010) Bone Marrow Transplant , vol.45 , pp. 1534-1539
    • Pallua, S.1    Giesinger, J.2    Oberguggenberger, A.3
  • 45
    • 78649635587 scopus 로고    scopus 로고
    • Measuring musculoskeletal symptoms in cancer survivors who receive hematopoietic cell transplantation
    • Syrjala K.L., Yi J.C., Artherholt S.B., et al. Measuring musculoskeletal symptoms in cancer survivors who receive hematopoietic cell transplantation. JCancer Surviv 2010, 4:225-235.
    • (2010) JCancer Surviv , vol.4 , pp. 225-235
    • Syrjala, K.L.1    Yi, J.C.2    Artherholt, S.B.3
  • 46
    • 84869213493 scopus 로고    scopus 로고
    • Delivering care to long-term adult survivors of hematopoietic cell transplantation
    • Syrjala K.L., Martin P.J., Lee S.J. Delivering care to long-term adult survivors of hematopoietic cell transplantation. JClin Oncol 2012, 30:3746-3751.
    • (2012) JClin Oncol , vol.30 , pp. 3746-3751
    • Syrjala, K.L.1    Martin, P.J.2    Lee, S.J.3
  • 47
    • 27244459165 scopus 로고    scopus 로고
    • Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States
    • Baker K.S., Loberiza F.R., Yu H., et al. Outcome of ethnic minorities with acute or chronic leukemia treated with hematopoietic stem-cell transplantation in the United States. JClin Oncol 2005, 23:7032-7042.
    • (2005) JClin Oncol , vol.23 , pp. 7032-7042
    • Baker, K.S.1    Loberiza, F.R.2    Yu, H.3
  • 48
    • 0142023889 scopus 로고    scopus 로고
    • Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada
    • Serna D.S., Lee S.J., Zhang M.J., et al. Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada. JClin Oncol 2003, 21:3754-3760.
    • (2003) JClin Oncol , vol.21 , pp. 3754-3760
    • Serna, D.S.1    Lee, S.J.2    Zhang, M.J.3
  • 49
    • 80053210063 scopus 로고    scopus 로고
    • The protective effect of neighborhood composition on increasing frailty among older Mexican Americans: a barrio advantage?
    • Aranda M.P., Ray L.A., Snih S.A., et al. The protective effect of neighborhood composition on increasing frailty among older Mexican Americans: a barrio advantage?. JAging Health 2011, 23:1189-1217.
    • (2011) JAging Health , vol.23 , pp. 1189-1217
    • Aranda, M.P.1    Ray, L.A.2    Snih, S.A.3
  • 50
    • 84877011939 scopus 로고    scopus 로고
    • Socioeconomic status as a predictor of melanoma survival in a series of 1083 cases from Brazil: just a marker of health services accessibility?
    • Quintella Mendes G.L., Koifman S. Socioeconomic status as a predictor of melanoma survival in a series of 1083 cases from Brazil: just a marker of health services accessibility?. Melanoma Res 2013, 23:199-205.
    • (2013) Melanoma Res , vol.23 , pp. 199-205
    • Quintella Mendes, G.L.1    Koifman, S.2
  • 51
    • 28744444180 scopus 로고    scopus 로고
    • National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report
    • Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report. Biol Blood Marrow Transplant 2005, 11:945-956.
    • (2005) Biol Blood Marrow Transplant , vol.11 , pp. 945-956
    • Filipovich, A.H.1    Weisdorf, D.2    Pavletic, S.3
  • 52
    • 0032984825 scopus 로고    scopus 로고
    • Integrating response shift into health-related quality of life research: a theoretical model
    • Sprangers M.A.G., Schwartz C.E. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med 1999, 48:1507-1515.
    • (1999) Soc Sci Med , vol.48 , pp. 1507-1515
    • Sprangers, M.A.G.1    Schwartz, C.E.2
  • 53
    • 84876498774 scopus 로고    scopus 로고
    • Assessment of response shift using two structural equation modeling techniques
    • Gandhi P.K., Ried L.D., Huang I.C., et al. Assessment of response shift using two structural equation modeling techniques. Qual Life Res 2013, 22:461-471.
    • (2013) Qual Life Res , vol.22 , pp. 461-471
    • Gandhi, P.K.1    Ried, L.D.2    Huang, I.C.3
  • 54
    • 4344703446 scopus 로고    scopus 로고
    • Toward a theoretical model of quality-of-life appraisal: Implications of findings from studies of response shift
    • Rapkin B.D., Schwartz C.E. Toward a theoretical model of quality-of-life appraisal: Implications of findings from studies of response shift. Health Qual Life Outcomes 2004, 2:14.
    • (2004) Health Qual Life Outcomes , vol.2 , pp. 14
    • Rapkin, B.D.1    Schwartz, C.E.2
  • 55
    • 84874735103 scopus 로고    scopus 로고
    • The role of recalibration response shift in explaining bodily pain in cancer patients undergoing invasive surgery: an empirical investigation of the Sprangers and Schwartz model
    • Visser M.R.M., Oort F.J., van Lanschot J.J.B., et al. The role of recalibration response shift in explaining bodily pain in cancer patients undergoing invasive surgery: an empirical investigation of the Sprangers and Schwartz model. Psychooncology 2013, 22:515-522.
    • (2013) Psychooncology , vol.22 , pp. 515-522
    • Visser, M.R.M.1    Oort, F.J.2    van Lanschot, J.J.B.3
  • 56
    • 84887112382 scopus 로고    scopus 로고
    • Comparison between patient-reported and clinician-observed symptoms in oncology
    • Xiao C., Polomano R., Bruner D.W. Comparison between patient-reported and clinician-observed symptoms in oncology. Cancer Nurs 2013, 36:E1-E16.
    • (2013) Cancer Nurs , vol.36
    • Xiao, C.1    Polomano, R.2    Bruner, D.W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.